Omics-based strategies in precision medicine: Toward a paradigm shift in inborn errors of metabolism investigations

International Journal of Molecular Sciences

Volumn 17, Issue 9, 2016, Pages

  Tebani, Abdellah ^a,b,c   Afonso, Carlos ^c   Marret, Stéphane ^a,b   Bekri, Soumeya ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c Normandie Université   (France)

Author keywords

Bioinformatics; Biomarkers; Chemometrics; Data integration; Inborn errors of metabolism; Machine learning; Mass spectrometry; Next generation sequencing; Omics; Precision medicine

Indexed keywords

DNA POLYMERASE;

BIOINFORMATICS; CHROMATIN IMMUNOPRECIPITATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA REPLICATION; DNA STRUCTURE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; INBORN ERROR OF METABOLISM; INTELLECTUAL IMPAIRMENT; ION MOBILITY SPECTROMETRY; MACHINE LEARNING; MASS SPECTROMETRY; NEXT GENERATION SEQUENCING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; PROTEOMICS; REVIEW; TRANSCRIPTOMICS; EPIGENETICS; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; METABOLISM; METABOLISM, INBORN ERRORS; METABOLOMICS; PROCEDURES; SENSITIVITY AND SPECIFICITY; SYSTEMS BIOLOGY; TRENDS;

EPIGENOMICS; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; METABOLISM, INBORN ERRORS; METABOLOMICS; PRECISION MEDICINE; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SYSTEMS BIOLOGY;

EID: 84987749377     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17091555     Document Type: Review

References (188)

1. Collins, F.S.; Varmus, H. A new initiative on precision medicine. N. Engl. J. Med. 2015, 372, 793-795. [CrossRef] [PubMed]
2. Ahn, A.C.; Tewari, M.; Poon, C.S.; Phillips, R.S. The limits of reductionism in medicine: Could systems biology offer an alternative? PLoS Med. 2006, 3, e208. [CrossRef] [PubMed]
3. Van Regenmortel M.H. Reductionism and complexity in molecular biology: Scientists now have the tools to unravel biological and overcome the limitations of reductionism. EMBO Rep. 2004, 5, 1016-1020. [CrossRef] [PubMed]
4. Aon, M.A. Complex systems biology of networks: The riddle and the challenge. In Systems Biology of Metabolic and Signaling Networks; Springer Berlin Heidelberg: Heidelberg, Germany, 2014; pp. 19-35.
5. Kitano, H. Systems biology: A brief overview. Science 2002, 295, 1662-1664. [CrossRef] [PubMed]
6. Lanpher, B.; Brunetti-Pierri, N.; Lee, B. Inborn errors of metabolism: The flux from mendelian to complex diseases. Nat. Rev. Genet. 2006, 7, 449-460. [CrossRef] [PubMed]
7. Watson, J.D.; Crick, F.H. The structure of DNA. Cold Spring Harb. Symp. Quant. Biol. 1953, 18, 123-131. [CrossRef] [PubMed]
8. Goodwin, S.; McPherson, J.D.; McCombie W.R. Coming of age: Ten years of next-generation sequencing technologies. Nat. Rev. Genet. 2016, 17, 333-351. [CrossRef] [PubMed]
9. Yang, Y.; Muzny, D.M.; Reid, J.G.; Bainbridge, M.N.; Willis, A.; Ward, P.A.; Braxton, A.; Beuten, J.; Xia, F.; Niu, Z. et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 2013, 369, 1502-1511. [CrossRef] [PubMed]
10. Van Karnebeek, C.D.; Bonafe, L.; Wen, X.Y.; Tarailo-Graovac, M.; Balzano, S.; Royer-Bertrand, B.; Ashikov, A.; Garavelli, L.; Mammi, I.; Turolla, L. et al. Nans-mediated synthesis of sialic acid is required for brain and skeletal development. Nat. Genet. 2016, 48, 777-784. [CrossRef] [PubMed]
11. Tarailo-Graovac, M.; Shyr, C.; Ross, C.J.; Horvath, G.A.; Salvarinova, R.; Ye, X.C.; Zhang, L.H.; Bhavsar, A.P.; Lee, J.J.; Drogemoller, B.I. et al. Exome sequencing and the management of neurometabolic disorders. N. Engl. J. Med. 2016, 374, 2246-2255. [CrossRef] [PubMed]
12. Worthey, E.A.; Mayer, A.N.; Syverson, G.D.; Helbling, D.; Bonacci, B.B.; Decker, B.; Serpe, J.M.; Dasu, T.; Tschannen, M.R.; Veith, R.L. et al. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 2011, 13, 255-262. [CrossRef] [PubMed]
13. Benson, M. Clinical implications of omics and systems medicine: Focus on predictive and individualized treatment. J. Intern. Med. 2016, 279, 229-240. [CrossRef] [PubMed]
14. Yohe, S.; Hauge, A.; Bunjer, K.; Kemmer, T.; Bower, M.; Schomaker, M.; Onsongo, G.; Wilson, J.; Erdmann, J.; Zhou, Y. et al. Clinical validation of targeted next-generation sequencing for inherited disorders. Arch. Pathol. Lab. Med. 2015, 139, 204-210. [CrossRef] [PubMed]
15. Yubero, D.; Brandi, N.; Ormazabal, A.; Garcia-Cazorla, A.; Perez-Duenas, B.; Campistol, J.; Ribes, A.; Palau, F.; Artuch, R.; Armstrong, J. et al. Targeted next generation sequencing in patients with inborn errors of metabolism. PLoS ONE 2016, 11, e0156359. [CrossRef] [PubMed]
16. Cirulli, E.T.; Goldstein, D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet. 2010, 11, 415-425. [CrossRef] [PubMed]
17. Stranneheim, H.; Wedell, A. Exome and genome sequencing: A revolution for the discovery and diagnosis of monogenic disorders. J. Intern. Med. 2016, 279, 3-15. [CrossRef] [PubMed]
18. Meienberg, J.; Zerjavic, K.; Keller, I.; Okoniewski, M.; Patrignani, A.; Ludin, K.; Xu, Z.; Steinmann, B.; Carrel, T.; Rothlisberger, B. et al. New insights into the performance of human whole-exome capture platforms. Nucleic Acids Res. 2015, 43, e76. [CrossRef] [PubMed]
19. Mortazavi, A.; Williams, B.A.; McCue, K.; Schaeffer, L.; Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 2008, 5, 621-628. [CrossRef] [PubMed]
20. Mensaert, K.; Denil, S.; Trooskens, G.; van Criekinge, W.; Thas, O.; de Meyer, T. Next-generation technologies and data analytical approaches for epigenomics. Environ. Mol. Mutagen. 2014, 55, 155-170. [CrossRef] [PubMed]
21. Sanger, F.; Nicklen, S.; Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977, 74, 5463-5467. [CrossRef] [PubMed]
22. Marsh, M.; Tu, O.; Dolnik, V.; Roach, D.; Solomon, N.; Bechtol, K.; Smietana, P.; Wang, L.; Li, X.; Cartwright, P. et al. High-throughput DNA sequencing on a capillary array electrophoresis system. J. Capill. Electrophor. 1997, 4, 83-89.
23. McBride, L.J.; Koepf, S.M.; Gibbs, R.A.; Salser, W.; Mayrand, P.E.; Hunkapiller, M.W.; Kronick, M.N. Automated DNA sequencing methods involving polymerase chain reaction. Clin. Chem. 1989, 35, 2196-2201. [PubMed]
24. Prober, J.M.; Trainor, G.L.; Dam, R.J.; Hobbs, F.W.; Robertson, C.W.; Zagursky, R.J.; Cocuzza, A.J.; Jensen, M.A.; Baumeister, K. A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides. Science 1987, 238, 336-341. [CrossRef] [PubMed]
25. Venter, J.C.; Adams, M.D.; Myers, E.W.; Li, P.W.; Mural, R.J.; Sutton, G.G.; Smith, H.O.; Yandell, M.; Evans, C.A.; Holt, R.A. et al. The sequence of the human genome. Science 2001, 291, 1304-1351. [CrossRef] [PubMed]
26. Lander, E.S.; Linton, L.M.; Birren, B.; Nusbaum, C.; Zody, M.C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W. et al. Initial sequencing and analysis of the human genome. Nature 2001, 409, 860-921. [CrossRef] [PubMed]
27. Reuter, J.A.; Spacek, D.V.; Snyder, M.P. High-throughput sequencing technologies. Mol. Cell 2015, 58, 586-597. [CrossRef] [PubMed]
28. Head, S.R.; Komori, H.K.; LaMere, S.A.; Whisenant, T.; van Nieuwerburgh, F.; Salomon, D.R.; Ordoukhanian, P. Library construction for next-generation sequencing: Overviews and challenges. Biotechniques 2014, 56, 61. [CrossRef] [PubMed]
29. Mardis, E.R. Next-generation sequencing platforms. Annu. Rev. Anal. Chem. 2013, 6, 287-303. [CrossRef] [PubMed]
30. Lim, E.C.; Brett, M.; Lai, A.H.; Lee, S.P.; Tan, E.S.; Jamuar, S.S.; Ng, I.S.; Tan, E.C. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients. Hum. Genom. 2015, 9, 33. [CrossRef] [PubMed]
31. Taylor, R.W.; Pyle, A.; Griffin, H.; Blakely, E.L.; Duff, J.; He, L.; Smertenko, T.; Alston, C.L.; Neeve, V.C.; Best, A. et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA 2014, 312, 68-77. [CrossRef] [PubMed]
32. Howard, H.C.; Knoppers, B.M.; Cornel, M.C.; Wright Clayton, E.; Senecal, K.; Borry, P. Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes. Eur. J. Hum. Genet. 2015, 23, 1593-1600. [CrossRef] [PubMed]
33. Ashley, E.A. Towards precision medicine. Nat. Rev. Genet. 2016, 17, 507-522. [CrossRef] [PubMed]
34. Goldfeder, R.L.; Ashley, E.A. A precision metric for clinical genome sequencing. bioRxiv 2016, 051490. [CrossRef]
35. Bird, A. Perceptions of epigenetics. Nature 2007, 447, 396-398. [CrossRef] [PubMed]
36. Huang, B.; Jiang, C.; Zhang, R. Epigenetics: The language of the cell? Epigenomics 2014, 6, 73-88. [CrossRef] [PubMed]
37. Sadakierska-Chudy, A.; Filip, M. A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs. Neurotox. Res. 2015, 27, 172-197. [CrossRef] [PubMed]
38. Sadakierska-Chudy, A.; Kostrzewa, R.M.; Filip, M. A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants. Neurotox. Res. 2015, 27, 84-97. [CrossRef] [PubMed]
39. Kundaje, A.; Meuleman, W.; Ernst, J.; Bilenky, M.; Yen, A.; Heravi-Moussavi, A.; Kheradpour, P.; Zhang, Z.; Wang, J.; Ziller, M.J. et al. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518, 317-330. [CrossRef] [PubMed]
40. Barski, A.; Cuddapah, S.; Cui, K.; Roh, T.Y.; Schones, D.E.; Wang, Z.; Wei, G.; Chepelev, I.; Zhao, K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129, 823-837. [CrossRef] [PubMed]
41. Yaragatti, M.; Basilico, C.; Dailey, L. Identification of active transcriptional regulatory modules by the functional assay of DNA from nucleosome-free regions. Genome Res. 2008, 18, 930-938. [CrossRef] [PubMed]
42. Lister, R.; O’Malley, R.C.; Tonti-Filippini, J.; Gregory, B.D.; Berry, C.C.; Millar, A.H.; Ecker, J.R. Highly integrated single-base resolution maps of the epigenome in arabidopsis. Cell 2008, 133, 523-536. [CrossRef] [PubMed]
43. Buenrostro, J.D.; Wu, B.; Chang, H.Y.; Greenleaf, W.J. Atac-seq: A method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 2015, 109. [CrossRef]
44. Meyer, C.A.; Liu, X.S. Identifying and mitigating bias in next-generation sequencing methods for chromatin biology. Nat. Rev. Genet. 2014, 15, 709-721. [CrossRef] [PubMed]
45. Guay, S.P.; Voisin, G.; Brisson, D.; Munger, J.; Lamarche, B.; Gaudet, D.; Bouchard, L. Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. Epigenomics 2012, 4, 623-639. [CrossRef] [PubMed]
46. Wang, Z.; Gerstein, M.; Snyder, M. RNA-seq: A revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10, 57-63. [CrossRef] [PubMed]
47. Nogales-Gadea, G.; Consuegra-Garcia, I.; Rubio, J.C.; Arenas, J.; Cuadros, M.; Camara, Y.; Torres-Torronteras, J.; Fiuza-Luces, C.; Lucia, A.; Martin, M.A. et al. A transcriptomic approach to search for novel phenotypic regulators in mcardle disease. PLoS ONE 2012, 7, e31718. [CrossRef] [PubMed]
48. Mazzoccoli, G.; Tomanin, R.; Mazza, T.; D’Avanzo, F.; Salvalaio, M.; Rigon, L.; Zanetti, A.; Pazienza, V.; Francavilla, M.; Giuliani, F. et al. Circadian transcriptome analysis in human fibroblasts from hunter syndrome and impact of iduronate-2-sulfatase treatment. BMC Med. Genom. 2013, 6, 37. [CrossRef] [PubMed]
49. Tringham, M.; Kurko, J.; Tanner, L.; Tuikkala, J.; Nevalainen, O.S.; Niinikoski, H.; Nanto-Salonen, K.; Hietala, M.; Simell, O.; Mykkanen, J. Exploring the transcriptomic variation caused by the finnish founder mutation of lysinuric protein intolerance (LPI). Mol. Genet. Metab. 2012, 105, 408-415. [CrossRef] [PubMed]
50. Dauphinot, L.; Mockel, L.; Cahu, J.; Jinnah, H.A.; Ledroit, M.; Potier, M.C.; Ceballos-Picot, I. Transcriptomic approach to Lesch-Nyhan disease. Nucleosides Nucleotides Nucleic Acids 2014, 33, 208-217. [CrossRef] [PubMed]
51. Cluzeau, C.V.; Watkins-Chow, D.E.; Fu, R.; Borate, B.; Yanjanin, N.; Dail, M.K.; Davidson, C.D.; Walkley, S.U.; Ory, D.S.; Wassif, C.A. et al. Microarray expression analysis and identification of serum biomarkers for niemann-pick disease, type c1. Hum. Mol. Genet. 2012, 21, 3632-3646. [CrossRef] [PubMed]
52. Cajka, T.; Fiehn, O. Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics. Anal. Chem. 2015, 88, 524-545. [CrossRef] [PubMed]
53. Scherl, A. Clinical protein mass spectrometry. Methods 2015, 81, 3-14. [CrossRef] [PubMed]
54. Kusebauch, U.; Campbell, D.S.; Deutsch, E.W.; Chu, C.S.; Spicer, D.A.; Brusniak, M.-Y.; Slagel, J.; Sun, Z.; Stevens, J.; Grimes, B. et al. Human srmatlas: A resource of targeted assays to quantify the complete human proteome. Cell 2016, 166, 766-778. [CrossRef] [PubMed]
55. May, J.C.; McLean, J.A. Advanced multidimensional separations in mass spectrometry: Navigating the big data deluge. Annu. Rev. Anal. Chem. 2016, 9, 387-409. [CrossRef] [PubMed]
56. Tebani, A.; Schmitz-Afonso, I.; Rutledge, D.N.; Gonzalez, B.J.; Bekri, S.; Afonso, C. Optimization of a liquid chromatography ion mobility-mass spectrometry method for untargeted metabolomics using experimental design and multivariate data analysis. Anal. Chim. Acta 2016, 913, 55-62. [CrossRef] [PubMed]
57. James, P. Protein identification in the post-genome era: The rapid rise of proteomics. Quart. Rev. Biophys. 1997, 30, 279-331. [CrossRef]
58. Khoury, G.A.; Baliban, R.C.; Floudas, C.A. Proteome-wide post-translational modification statistics: Frequency analysis and curation of the swiss-prot database. Sci. Rep. 2011, 1, 90. [CrossRef] [PubMed]
59. Betzen, C.; Alhamdani, M.S.S.; Lueong, S.; Schröder, C.; Stang, A.; Hoheisel, J.D. Clinical proteomics: Promises, challenges and limitations of affinity arrays. Proteom. Clin. Appl. 2015, 9, 342-347. [CrossRef] [PubMed]
60. Sabbagh, B.; Mindt, S.; Neumaier, M.; Findeisen, P. Clinical applications of ms-based protein quantification. Proteom. Clin. Appl. 2016, 10, 323-345. [CrossRef] [PubMed]
61. Lassman, M.E.; McAvoy, T.; Chappell, D.L.; Lee, A.Y.; Zhao, X.X.; Laterza, O.F. The clinical utility of mass spectrometry based protein assays. Clin. Chim. Acta 2016, 459, 155-161. [CrossRef] [PubMed]
62. Kovacevic, L.; Lu, H.; Goldfarb, D.S.; Lakshmanan, Y.; Caruso, J.A. Urine proteomic analysis in cystinuric children with renal stones. J. Pediatr. Urol. 2015, 11, 217.e1-217.e6. [CrossRef] [PubMed]
63. Heywood, W.E.; Camuzeaux, S.; Doykov, I.; Patel, N.; Preece, R.L.; Footitt, E.; Cleary, M.; Clayton, P.; Grunewald, S.; Abulhoul, L. et al. Proteomic discovery and development of a multiplexed targeted mrm-lc-ms/ms assay for urine biomarkers of extracellular matrix disruption in mucopolysaccharidoses I, II, and VI. Anal. Chem. 2015, 87, 12238-12244. [CrossRef] [PubMed]
64. Williams, E.G.; Wu, Y.; Jha, P.; Dubuis, S.; Blattmann, P.; Argmann, C.A.; Houten, S.M.; Amariuta, T.; Wolski, W.; Zamboni, N. et al. Systems proteomics of liver mitochondria function. Science 2016, 352, aad0189. [CrossRef] [PubMed]
65. Martens, L. Bringing proteomics into the clinic: The need for the field to finally take itself seriously. Proteom. Clin. Appl. 2013, 7, 388-391. [CrossRef] [PubMed]
66. Holmes, E.; Wilson, I.D.; Nicholson, J.K. Metabolic phenotyping in health and disease. Cell 2008, 134, 714-717. [CrossRef] [PubMed]
67. Oliver, S.G.; Winson, M.K.; Kell, D.B.; Baganz, F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998, 16, 373-378. [CrossRef]
68. Nicholson, J.K.; Lindon, J.C.; Holmes, E. “Metabonomics”: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29, 1181-1189. [CrossRef] [PubMed]
69. Nicholson, J.K.; Holmes, E.; Kinross, J.M.; Darzi, A.W.; Takats, Z.; Lindon, J.C. Metabolic phenotyping in clinical and surgical environments. Nature 2012, 491, 384-392. [CrossRef] [PubMed]
70. Suhre, K.; Raffler, J.; Kastenmüller, G. Biochemical insights from population studies with genetics and metabolomics. Arch. Biochem. Biophys. 2016, 589, 168-176. [CrossRef] [PubMed]
71. Alonso, A.; Marsal, S.; Julia, A. Analytical methods in untargeted metabolomics: State of the art in 2015. Front. Bioeng. Biotechnol. 2015, 3, 23. [CrossRef] [PubMed]
72. Therrell, B.L.; Padilla, C.D.; Loeber, J.G.; Kneisser, I.; Saadallah, A.; Borrajo, G.J.; Adams, J. Current status of newborn screening worldwide:2015. Semin. Perinatol. 2015, 39, 171-187. [CrossRef] [PubMed]
73. Denes, J.; Szabo, E.; Robinette, S.L.; Szatmari, I.; Szonyi, L.; Kreuder, J.G.; Rauterberg, E.W.; Takats, Z. Metabonomics of newborn screening dried blood spot samples: A novel approach in the screening and diagnostics of inborn errors of metabolism. Anal. Chem. 2012, 84, 10113-10120. [CrossRef] [PubMed]
74. Aygen, S.; Durr, U.; Hegele, P.; Kunig, J.; Spraul, M.; Schafer, H.; Krings, D.; Cannet, C.; Fang, F.; Schutz, B. et al. NMR-based screening for inborn errors of metabolism: Initial results from a study on turkish neonates. JIMD Rep. 2014, 16, 101-111. [PubMed]
75. Miller, M.; Kennedy, A.; Eckhart, A.; Burrage, L.; Wulff, J.; Miller, L.D.; Milburn, M.; Ryals, J.; Beaudet, A.; Sun, Q. et al. Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism. J. Inherit. Metab. Dis. 2015, 38, 1029-1039. [CrossRef] [PubMed]
76. Tebani, A.; Abily-Donval, L.; Afonso, C.; Marret, S.; Bekri, S. Clinical metabolomics: The new metabolic window for inborn errors of metabolism investigations in the post-genomic era. Int. J. Mol. Sci. 2016, 17, 1167. [CrossRef] [PubMed]
77. Houle, D.; Govindaraju, D.R.; Omholt, S. Phenomics: The next challenge. Nat. Rev. Genet. 2010, 11, 855-866. [CrossRef] [PubMed]
78. Plomin, R.; Haworth, C.M.; Davis, O.S. Common disorders are quantitative traits. Nat. Rev. Genet. 2009, 10, 872-878. [CrossRef] [PubMed]
79. Bush, W.S.; Oetjens, M.T.; Crawford, D.C. Unravelling the human genome-phenome relationship using phenome-wide association studies. Nat. Rev. Genet. 2016, 17, 129-145. [CrossRef] [PubMed]
80. Bilder, R.M.; Sabb, F.W.; Cannon, T.D.; London, E.D.; Jentsch, J.D.; Parker, D.S.; Poldrack, R.A.; Evans, C.; Freimer, N.B. Phenomics: The systematic study of phenotypes on a genome-wide scale. Neuroscience 2009, 164, 30-42. [CrossRef] [PubMed]
81. Freimer, N.; Sabatti, C. The human phenome project. Nat. Genet. 2003, 34, 15-21. [CrossRef] [PubMed]
82. Gerlai, R. Phenomics: Fiction or the future? Trends Neurosci. 2002, 25, 506-509. [CrossRef]
83. Oetting W.S.; Robinson, P.N.; Greenblatt, M.S.; Cotton, R.G.; Beck, T.; Carey, J.C.; Doelken, S.C.; Girdea, M.; Groza, T.; Hamilton, C.M. et al. Getting ready for the human phenome project: The 2012 forum of the human variome project. Hum. Mutat. 2013, 34, 661-666. [CrossRef] [PubMed]
84. Groza, T.; Kohler, S.; Moldenhauer, D.; Vasilevsky, N.; Baynam, G.; Zemojtel, T.; Schriml, L.M.; Kibbe W.A.; Schofield, P.N.; Beck, T. et al. The human phenotype ontology: Semantic unification of common and rare disease. Am. J. Hum. Genet. 2015, 97, 111-124. [CrossRef] [PubMed]
85. Ritchie, M.D.; Holzinger, E.R.; Li, R.; Pendergrass, S.A.; Kim, D. Methods of integrating data to uncover genotype-phenotype interactions. Nat. Rev. Genet. 2015, 16, 85-97. [CrossRef] [PubMed]
86. Tracy, R.P. “Deep phenotyping”: Characterizing populations in the era of genomics and systems biology. Curr. Opin. Lipidol. 2008, 19, 151-157. [CrossRef] [PubMed]
87. Shameer, K.; Badgeley, M.A.; Miotto, R.; Glicksberg, B.S.; Morgan, J.W.; Dudley, J.T. Translational bioinformatics in the era of real-time biomedical, health care and wellness data streams. Brief. Bioinform. 2016. [CrossRef] [PubMed]
88. Kochinke, K.; Zweier, C.; Nijhof, B.; Fenckova, M.; Cizek, P.; Honti, F.; Keerthikumar, S.; Oortveld Merel, A.W.; Kleefstra, T.; Kramer, J.M. et al. Systematic phenomics analysis deconvolutes genes mutated in intellectual disability into biologically coherent modules. Am. J. Hum. Genet. 2016, 98, 149-164. [CrossRef] [PubMed]
89. Kim, S.; Herazo-Maya, J.D.; Kang, D.D.; Juan-Guardela, B.M.; Tedrow, J.; Martinez, F.J.; Sciurba, F.C.; Tseng, G.C.; Kaminski, N. Integrative phenotyping framework (iPF): Integrative clustering of multiple omics data identifies novel lung disease subphenotypes. BMC Genom. 2015, 16, 1-11. [CrossRef] [PubMed]
90. Mungall, C.J.; Washington, N.L.; Nguyen-Xuan, J.; Condit, C.; Smedley, D.; Kohler, S.; Groza, T.; Shefchek, K.; Hochheiser, H.; Robinson, P.N. et al. Use of model organism and disease databases to support matchmaking for human disease gene discovery. Hum. Mutat. 2015, 36, 979-984. [CrossRef] [PubMed]
91. Argmann, C.A.; Houten, S.M.; Zhu, J.; Schadt, E.E. A next generation multiscale view of inborn errors of metabolism. Cell Metab. 2016, 23, 13-26. [CrossRef] [PubMed]
92. Gligorijevic, V.; Przulj, N. Methods for biological data integration: Perspectives and challenges. J. R. Soc. Interface 2015, 12, 112. [CrossRef] [PubMed]
93. Wanichthanarak, K.; Fahrmann, J.F.; Grapov, D. Genomic, proteomic, and metabolomic data integration strategies. Biomark. Insights 2015, 10, 1-6. [PubMed]
94. Wahl, S.; Vogt, S.; Stuckler, F.; Krumsiek, J.; Bartel, J.; Kacprowski, T.; Schramm, K.; Carstensen, M.; Rathmann, W.; Roden, M. et al. Multi-omic signature of body weight change: Results from a population-based cohort study. BMC Med. 2015, 13, 48. [CrossRef] [PubMed]
95. Liu, W.; Bai, X.; Liu, Y.; Wang, W.; Han, J.; Wang, Q.; Xu, Y.; Zhang, C.; Zhang, S.; Li, X. et al. Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: Prostate cancer as a case. Sci. Rep. 2015, 5, 13192. [CrossRef] [PubMed]
96. Chen, R.; Mias, G.I.; Li-Pook-Than, J.; Jiang, L.; Lam, H.Y.K.; Chen, R.; Miriami, E.; Karczewski, K.J.; Hariharan, M.; Dewey, F.E. et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148, 1293-1307. [CrossRef] [PubMed]
97. Bartel, J.; Krumsiek, J.; Schramm, K.; Adamski, J.; Gieger, C.; Herder, C.; Carstensen, M.; Peters, A.; Rathmann, W.; Roden, M. et al. The human blood metabolome-transcriptome interface. PLoS Genet. 2015, 11, e1005274. [CrossRef] [PubMed]
98. Shin, S.Y.; Fauman, E.B.; Petersen, A.K.; Krumsiek, J.; Santos, R.; Huang, J.; Arnold, M.; Erte, I.; Forgetta, V.; Yang, T.P. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 2014, 46, 543-550. [CrossRef] [PubMed]
99. Petersen, A.K.; Zeilinger, S.; Kastenmuller, G.; Romisch-Margl, W.; Brugger, M.; Peters, A.; Meisinger, C.; Strauch, K.; Hengstenberg, C.; Pagel, P. et al. Epigenetics meets metabolomics: An epigenome-wide association study with blood serum metabolic traits. Hum. Mol. Genet. 2014, 23, 534-545. [CrossRef] [PubMed]
100. Ioannidis, J.P.; Khoury, M.J. Improving validation practices in “omics” research. Science 2011, 334, 1230-1232. [CrossRef] [PubMed]
101. Kolker, E.; Ozdemir, V.; Martens, L.; Hancock, W.; Anderson, G.; Anderson, N.; Aynacioglu, S.; Baranova, A.; Campagna, S.R.; Chen, R. et al. Toward more transparent and reproducible omics studies through a common metadata checklist and data publications. Omics 2014, 18, 10-14. [CrossRef] [PubMed]
102. Tenenbaum, J.D.; Sansone, S.A.; Haendel, M. A sea of standards for omics data: Sink or swim? JAMIA 2014, 21, 200-203. [CrossRef] [PubMed]
103. Chitayat, S.; Rudan, J.F. Chapter 10—Phenome centers and global harmonization. In Metabolic Phenotyping in Personalized and Public Healthcare; Academic Press: Boston, MA, USA, 2016; pp. 291-315.
104. Rocca-Serra, P.; Salek, R.M.; Arita, M.; Correa, E.; Dayalan, S.; Gonzalez-Beltran, A.; Ebbels, T.; Goodacre, R.; Hastings, J.; Haug, K. et al. Data standards can boost metabolomics research, and if there is a will, there is a way. Metabolomics 2016, 12, 14. [CrossRef] [PubMed]
105. Dunn, W.B.; Wilson, I.D.; Nicholls, A.W.; Broadhurst, D. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 2012, 4, 2249-2264. [CrossRef] [PubMed]
106. Walzer, M.; Pernas, L.E.; Nasso, S.; Bittremieux, W.; Nahnsen, S.; Kelchtermans, P.; Pichler, P.; van den Toorn, H.W.; Staes, A.; Vandenbussche, J. et al. Qcml: An exchange format for quality control metrics from mass spectrometry experiments. Mol. Cell. Proteom. 2014, 13, 1905-1913. [CrossRef] [PubMed]
107. Issaq, H.J.; Waybright, T.J.; Veenstra, T.D. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods. Electrophoresis 2011, 32, 967-975. [CrossRef] [PubMed]
108. Jonsson, P.; Wuolikainen, A.; Thysell, E.; Chorell, E.; Stattin, P.; Wikstrom, P.; Antti, H. Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples. Metabolomics 2015, 11, 1667-1678. [CrossRef] [PubMed]
109. Scherer, A. Batch Effects and Noise in Microarray Experiments: Sources and Solutions; John Wiley & Sons: Chichester, UK, 2009; Volume 868.
110. Vivian, J.; Rao, A.; Nothaft, F.A.; Ketchum, C.; Armstrong, J.; Novak, A.; Pfeil, J.; Narkizian, J.; Deran, A.D.; Musselman-Brown, A. et al. Rapid and efficient analysis of 20,000 RNA-Seq samples with toil. bioRxiv 2016. [CrossRef]
111. Church, D.M.; Schneider, V.A.; Steinberg, K.M.; Schatz, M.C.; Quinlan, A.R.; Chin, C.-S.; Kitts, P.A.; Aken, B.; Marth, G.T.; Hoffman, M.M. et al. Extending reference assembly models. Genome Biol. 2015, 16, 1-5. [CrossRef] [PubMed]
112. Goldfeder, R.L.; Priest, J.R.; Zook, J.M.; Grove, M.E.; Waggott, D.; Wheeler, M.T.; Salit, M.; Ashley, E.A. Medical implications of technical accuracy in genome sequencing. Genome Med. 2016, 8, 24. [CrossRef] [PubMed]
113. Tewhey, R.; Bansal, V.; Torkamani, A.; Topol, E.J.; Schork, N.J. The importance of phase information for human genomics. Nat. Rev. Genet. 2011, 12, 215-223. [CrossRef] [PubMed]
114. Zheng, G.X.; Lau, B.T.; Schnall-Levin, M.; Jarosz, M.; Bell, J.M.; Hindson, C.M.; Kyriazopoulou-Panagiotopoulou, S.; Masquelier, D.A.; Merrill, L.; Terry, J.M. et al. Haplotyping germline and cancer genomes with high-throughput linked-read sequencing. Nat. Biotechnol. 2016, 34, 303-311. [CrossRef] [PubMed]
115. Chaisson, M.J.; Huddleston, J.; Dennis, M.Y.; Sudmant, P.H.; Malig, M.; Hormozdiari, F.; Antonacci, F.; Surti, U.; Sandstrom, R.; Boitano, M. Resolving the complexity of the human genome using single-molecule sequencing. Nature 2015, 517, 608-611. [CrossRef] [PubMed]
116. Foquet, M.; Samiee, K.T.; Kong, X.; Chauduri, B.P.; Lundquist, P.M.; Turner, S.W.; Freudenthal, J.; Roitman, D.B. Improved fabrication of zero-mode waveguides for single-molecule detection. J. Appl. Phys. 2008, 103, 034301. [CrossRef]
117. Clarke, J.; Wu, H.-C.; Jayasinghe, L.; Patel, A.; Reid, S.; Bayley, H. Continuous base identification for single-molecule nanopore DNA sequencing. Nat. Nanotechnol. 2009, 4, 265-270. [CrossRef] [PubMed]
118. Vinaixa, M.; Schymanski, E.L.; Neumann, S.; Navarro, M.; Salek, R.M.; Yanes, O. Mass spectral databases for LC/MS-and GC/MS-based metabolomics: State of the field and future prospects. TrAC Trends Anal. Chem. 2016, 78, 23-35. [CrossRef]
119. Wu, L.; Candille, S.I.; Choi, Y.; Xie, D.; Jiang, L.; Li-Pook-Than, J.; Tang, H.; Snyder, M. Variation and genetic control of protein abundance in humans. Nature 2013, 499, 79-82. [CrossRef] [PubMed]
120. Vogel, C.; Marcotte, E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 2012, 13, 227-232. [CrossRef] [PubMed]
121. Bittremieux, W.; Valkenborg, D.; Martens, L.; Laukens, K. Computational quality control tools for mass spectrometry proteomics. Proteomics 2016. [CrossRef] [PubMed]
122. Deutsch, E.W.; Overall, C.M.; van Eyk, J.E.; Baker, M.S.; Paik, Y.-K.; Weintraub, S.T.; Lane, L.; Martens, L.; Vandenbrouck, Y.; Kusebauch, U. et al. Human proteome project mass spectrometry data interpretation guidelines 2.1. J. Proteome Res. 2016. [CrossRef] [PubMed]
123. Whiteaker, J.R.; Zhao, L.; Anderson, L.; Paulovich, A.G. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteom. 2010, 9, 184-196. [CrossRef] [PubMed]
124. Fehniger, T.E.; Boja, E.S.; Rodriguez, H.; Baker, M.S.; Marko-Varga, G. Four areas of engagement requiring strengthening in modern proteomics today. J. Proteome Res. 2014, 13, 5310-5318. [CrossRef] [PubMed]
125. Shang, J.; Zhu, F.; Vongsangnak W.; Tang, Y.; Zhang W.; Shen, B. Evaluation and comparison of multiple aligners for next-generation sequencing data analysis. BioMed Res. Int. 2014, 2014, 309650. [CrossRef] [PubMed]
126. Pabinger, S.; Dander, A.; Fischer, M.; Snajder, R.; Sperk, M.; Efremova, M.; Krabichler, B.; Speicher, M.R.; Zschocke, J.; Trajanoski, Z. A survey of tools for variant analysis of next-generation genome sequencing data. Brief. Bioinform. 2014, 15, 256-278. [CrossRef] [PubMed]
127. Evani, U.S.; Challis, D.; Yu, J.; Jackson, A.R.; Paithankar, S.; Bainbridge, M.N.; Jakkamsetti, A.; Pham, P.; Coarfa, C.; Milosavljevic, A. Atlas2 cloud: A framework for personal genome analysis in the cloud. BMC Genom. 2012, 13, S19. [CrossRef] [PubMed]
128. Cibulskis, K.; Lawrence, M.S.; Carter, S.L.; Sivachenko, A.; Jaffe, D.; Sougnez, C.; Gabriel, S.; Meyerson, M.; Lander, E.S.; Getz, G. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 2013, 31, 213-219. [CrossRef] [PubMed]
129. Koboldt, D.C.; Zhang, Q.; Larson, D.E.; Shen, D.; McLellan, M.D.; Lin, L.; Miller, C.A.; Mardis, E.R.; Ding, L.; Wilson, R.K. Varscan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012, 22, 568-576. [CrossRef] [PubMed]
130. McKenna, A.; Hanna, M.; Banks, E.; Sivachenko, A.; Cibulskis, K.; Kernytsky, A.; Garimella, K.; Altshuler, D.; Gabriel, S.; Daly, M. The genome analysis toolkit: A mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20, 1297-1303. [CrossRef] [PubMed]
131. Spencer, D.H.; Tyagi, M.; Vallania, F.; Bredemeyer, A.J.; Pfeifer, J.D.; Mitra, R.D.; Duncavage, E.J. Performance of common analysis methods for detecting low-frequency single nucleotide variants in targeted next-generation sequence data. J. Mol. Diagn. 2014, 16, 75-88. [CrossRef] [PubMed]
132. Manrai, A.K.; Funke, B.H.; Rehm, H.L.; Olesen, M.S.; Maron, B.A.; Szolovits, P.; Margulies, D.M.; Loscalzo, J.; Kohane, I.S. Genetic misdiagnoses and the potential for health disparities. N. Engl. J. Med. 2016, 375, 655-665. [CrossRef] [PubMed]
133. Gullapalli, R.R.; Desai, K.V.; Santana-Santos, L.; Kant, J.A.; Becich, M.J. Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics. J. Pathol. Inform. 2012, 3, 40. [PubMed]
134. Deutsch, E.W. File formats commonly used in mass spectrometry proteomics. Mol. Cell. Proteom. 2012, 11, 1612-1621. [CrossRef] [PubMed]
135. Misra, B.B.; van der Hooft, J.J. Updates in metabolomics tools and resources: 2014-2015. Electrophoresis 2016, 37, 86-110. [CrossRef] [PubMed]
136. Annesley, T.; Diamandis, E.; Bachmann, L.; Hanash, S.; Hart, B.; Javahery, R.; Singh, R.; Smith, R. A spectrum of views on clinical mass spectrometry. Clin. Chem. 2016, 62, 30-36. [CrossRef] [PubMed]
137. Lathrop, J.T.; Jeffery, D.A.; Shea, Y.R.; Scholl, P.F.; Chan, M.M. US food and drug administration perspectives on clinical mass spectrometry. Clin. Chem. 2016, 62, 41-47. [CrossRef] [PubMed]
138. Levin, N.; Salek, R.M.; Steinbeck, C. Chapter 11—From databases to big data. In Metabolic Phenotyping in Personalized and Public Healthcare; Academic Press: Boston, MA, USA, 2016; pp. 317-331.
139. GTEx Consortium. The genotype-tissue expression (GTEX) pilot analysis: Multitissue gene regulation in humans. Science 2015, 348, 648-660.
140. Torell, F.; Bennett, K.; Cereghini, S.; Rannar, S.; Lundstedt-Enkel, K.; Moritz, T.; Haumaitre, C.; Trygg, J.; Lundstedt, T. Multi-organ contribution to the metabolic plasma profile using hierarchical modelling. PLoS ONE 2015, 10, e0129260. [CrossRef] [PubMed]
141. Do, K.T.; Kastenmüller, G.; Mook-Kanamori, D.O.; Yousri, N.A.; Theis, F.J.; Suhre, K.; Krumsiek, J. Network-based approach for analyzing intra-and interfluid metabolite associations in human blood, urine, and saliva. J. Proteome Res. 2015, 14, 1183-1194. [CrossRef] [PubMed]
142. McGregor, K.; Bernatsky, S.; Colmegna, I.; Hudson, M.; Pastinen, T.; Labbe, A.; Greenwood, C.M.T. An evaluation of methods correcting for cell-type heterogeneity in DNA methylation studies. Genome Biol. 2016, 17, 1-17. [CrossRef] [PubMed]
143. Buettner, F.; Natarajan, K.N.; Casale, F.P.; Proserpio, V.; Scialdone, A.; Theis, F.J.; Teichmann, S.A.; Marioni, J.C.; Stegle, O. Computational analysis of cell-to-cell heterogeneity in single-cell RNA-Sequencing data reveals hidden subpopulations of cells. Nat. Biotechnol. 2015, 33, 155-160. [CrossRef] [PubMed]
144. Houseman, E.A.; Molitor, J.; Marsit, C.J. Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics 2014, 30, 1431-1439. [CrossRef] [PubMed]
145. Bock, C.; Farlik, M.; Sheffield, N.C. Multi-omics of single cells: Strategies and applications. Trends Biotechnol. 2016, 34, 605-608. [CrossRef] [PubMed]
146. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001, 69, 89-95.
147. Halim, A.-B. Biomarkers in Drug Development: A Useful Tool but Discrepant Results May Have a Major Impact; INTECH Open Access Publisher: Rijeka, Croatia, 2011.
148. Micheel, C.M.; Nass, S.J.; Omenn, G.S. Evolution of Translational Omics: Lessons Learned and the Path Forward; National Academies Press: Washington, DC, USA, 2012.
149. Feuerstein, G.; Dormer, C.; Ruffolo, R.; Stiles, G.; Walsh, F.; Rutkowski, J. Translational medicine perspectives of biomarkers in drug discovery and development. Part I. Target selection and validation-biomarkers take center stage. Int. Drug Discov. 2007, 2, 36-43.
150. Brünner, N. What is the difference between “predictive and prognostic biomarkers”? Can you give some examples. Connection 2009, 13, 18.
151. Frank, R.; Hargreaves, R. Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2003, 2, 566-580. [CrossRef] [PubMed]
152. Horvath, A.R.; Lord, S.J.; StJohn, A.; Sandberg, S.; Cobbaert, C.M.; Lorenz, S.; Monaghan, P.J.; Verhagen-Kamerbeek W.D.J.; Ebert, C.; Bossuyt, P.M.M. From biomarkers to medical tests: The changing landscape of test evaluation. Clin. Chim. Acta 2014, 427, 49-57. [CrossRef] [PubMed]
153. Hotelling, H. Analysis of a complex of statistical variables into principal components. J. Educ. Psychol. 1933, 24, 417. [CrossRef]
154. Rutledge, D.N.; Bouveresse, D.J.-R. Independent components analysis with the jade algorithm. TrAC Trends Anal. Chem. 2013, 50, 22-32. [CrossRef]
155. Hartigan, J.A.; Wong, M.A. Algorithm as 136: A k-means clustering algorithm. J. R. Stat. Soc. Ser. C 1979, 28, 100-108. [CrossRef]
156. Johnson, S.C. Hierarchical clustering schemes. Psychometrika 1967, 32, 241-254. [CrossRef] [PubMed]
157. Kohonen, T. The self-organizing map. Proc. IEEE 1990, 78, 1464-1480. [CrossRef]
158. Wold, S.; Sjöström, M.; Eriksson, L. Pls-regression: A basic tool of chemometrics. Chemom. Intell. Lab. Syst. 2001, 58, 109-130. [CrossRef]
159. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS). J. Chemom. 2002, 16, 119-128. [CrossRef]
160. Cortes, C.; Vapnik, V. Support-vector networks. Mach. Learn. 1995, 20, 273-297. [CrossRef]
161. McShane, L.M.; Cavenagh, M.M.; Lively, T.G.; Eberhard, D.A.; Bigbee, W.L.; Williams, P.M.; Mesirov, J.P.; Polley, M.-Y.C.; Kim, K.Y.; Tricoli, J.V. et al. Criteria for the use of omics-based predictors in clinical trials. Nature 2013, 502, 317-320. [CrossRef] [PubMed]
162. Satagopam, V.; Gu, W.; Eifes, S.; Gawron, P.; Ostaszewski, M.; Gebel, S.; Barbosa-Silva, A.; Balling, R.; Schneider, R. Integration and visualization of translational medicine data for better understanding of human diseases. Big Data 2016, 4, 97-108. [CrossRef] [PubMed]
163. Offroy, M.; Duponchel, L. Topological data analysis: A promising big data exploration tool in biology, analytical chemistry and physical chemistry. Anal. Chim. Acta 2016, 910, 1-11. [CrossRef] [PubMed]
164. Lum, P.; Singh, G.; Lehman, A.; Ishkanov, T.; Vejdemo-Johansson, M.; Alagappan, M.; Carlsson, J.; Carlsson, G. Extracting insights from the shape of complex data using topology. Sci. Rep. 2013, 3, 1236. [CrossRef] [PubMed]
165. Carlsson, G. Topology and data. Bull. Am. Math. Soc. 2009, 46, 255-308. [CrossRef]
166. Nielson, J.L.; Paquette, J.; Liu, A.W.; Guandique, C.F.; Tovar, C.A.; Inoue, T.; Irvine, K.-A.; Gensel, J.C.; Kloke, J.; Petrossian, T.C. et al. Topological data analysis for discovery in preclinical spinal cord injury and traumatic brain injury. Nat. Commun. 2015, 6, 8581. [CrossRef] [PubMed]
167. Salazar, J.; Amri, H.; Noursi, D.; Abu-Asab, M. Computational tools for parsimony phylogenetic analysis of omics data. Omics J. Integr. Biol. 2015, 19, 471-477. [CrossRef] [PubMed]
168. Altman, R.B.; Khuri, N.; Salit, M.; Giacomini, K.M. Unmet needs: Research helps regulators do their jobs. Sci. Transl. Med. 2015, 7, 315ps22. [CrossRef] [PubMed]
169. Zerhouni, E.; Hamburg, M. The need for global regulatory harmonization: A public health imperative. Sci. Transl. Med. 2016, 8, 338ed6. [CrossRef] [PubMed]
170. Jiang, X.; Zhao, Y.; Wang, X.; Malin, B.; Wang, S.; Ohno-Machado, L.; Tang, H. A community assessment of privacy preserving techniques for human genomes. BMC Med. Inform. Decis. Mak. 2014, 14, 1-10. [CrossRef] [PubMed]
171. Shoenbill, K.; Fost, N.; Tachinardi, U.; Mendonca, E.A. Genetic data and electronic health records: A discussion of ethical, logistical and technological considerations. J. Am. Med. Inform. Assoc. 2014, 21, 171-180. [CrossRef] [PubMed]
172. Poste, G. Bring on the biomarkers. Nature 2011, 469, 156-157. [CrossRef] [PubMed]
173. Gligorijevic, V.; Malod-Dognin, N.; Przulj, N. Integrative methods for analyzing big data in precision medicine. Proteomics 2016, 16, 741-758. [CrossRef] [PubMed]
174. Li, L.; Cheng, W.Y.; Glicksberg, B.S.; Gottesman, O.; Tamler, R.; Chen, R.; Bottinger, E.P.; Dudley, J.T. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci. Transl. Med. 2015, 7, 311ra174. [CrossRef] [PubMed]
175. Asai, Y.; Abe, T.; Li, L.; Oka, H.; Nomura, T.; Kitano, H. Databases for multilevel biophysiology research available at physiome.jp. Front. Physiol. 2015, 6, 251. [CrossRef] [PubMed]
176. Garny, A.; Cooper, J.; Hunter, P.J. Toward a VPH/physiome toolkit. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2, 134-147. [CrossRef] [PubMed]
177. Clancy, C.E.; An, G.; Cannon W.R.; Liu, Y.; May, E.E.; Ortoleva, P.; Popel, A.S.; Sluka, J.P.; Su, J.; Vicini, P. et al. Multiscale modeling in the clinic: Drug design and development. Ann. Biomed. Eng. 2016, 44, 2591-2610. [CrossRef] [PubMed]
178. Henricks, W.H.; Karcher, D.S.; Harrison, J.H.; Sinard, J.H.; Riben, M.W.; Boyer, P.J.; Plath, S.; Thompson, A.; Pantanowitz, L. Pathology informatics essentials for residents: A flexible informatics curriculum linked to accreditation council for graduate medical education milestones. J. Pathol. Inform. 2016, 7, 27. [PubMed]
179. Louis, D.N.; Feldman, M.; Carter, A.B.; Dighe, A.S.; Pfeifer, J.D.; Bry, L.; Almeida, J.S.; Saltz, J.; Braun, J.; Tomaszewski, J.E. Computational pathology: A path ahead. Arch. Pathol. Lab. Med. 2015, 140, 41-50. [CrossRef] [PubMed]
180. Louis, D.N.; Gerber, G.K.; Baron, J.M.; Bry, L.; Dighe, A.S.; Getz, G.; Higgins, J.M.; Kuo, F.C.; Lane, W.J.; Michaelson, J.S. Computational pathology: An emerging definition. Arch. Pathol. Lab. Med. 2014, 138, 1133-1138. [CrossRef] [PubMed]
181. Sirintrapun, S.J.; Zehir, A.; Syed, A.; Gao, J.; Schultz, N.; Cheng, D.T. Translational bioinformatics and clinical research (biomedical) informatics. Clin. Lab. Med. 2016, 36, 153-181. [CrossRef] [PubMed]
182. Miotto, R.; Li, L.; Kidd, B.A.; Dudley, J.T. Deep patient: An unsupervised representation to predict the future of patients from the electronic health records. Sci. Rep. 2016, 6, 26094. [CrossRef] [PubMed]
183. Soualmia, L.F.; Lecroq, T. Bioinformatics methods and tools to advance clinical care. Findings from the yearbook 2015 section on bioinformatics and translational informatics. Yearb. Med. Inform. 2015, 10, 170-173. [CrossRef] [PubMed]
184. Tenenbaum, J.D.; Avillach, P.; Benham-Hutchins, M.; Breitenstein, M.K.; Crowgey, E.L.; Hoffman, M.A.; Jiang, X.; Madhavan, S.; Mattison, J.E.; Nagarajan, R. et al. An informatics research agenda to support precision medicine: Seven key areas. JAMIA 2016, 23, 791-795. [CrossRef] [PubMed]
185. Altman, R.B.; Prabhu, S.; Sidow, A.; Zook, J.M.; Goldfeder, R.; Litwack, D.; Ashley, E.; Asimenos, G.; Bustamante, C.D.; Donigan, K. et al. A research roadmap for next-generation sequencing informatics. Sci. Transl. Med. 2016, 8, 335ps310. [CrossRef] [PubMed]
186. Sahoo, S.; Franzson, L.; Jonsson, J.J.; Thiele, I. A compendium of inborn errors of metabolism mapped onto the human metabolic network. Mol. BioSyst. 2012, 8, 2545-2558. [CrossRef] [PubMed]
187. Cho, D.-Y.; Kim, Y.-A.; Przytycka, T.M. Chapter 5: Network biology approach to complex diseases. PLoS Comput. Biol. 2012, 8, e1002820. [CrossRef] [PubMed]
188. Hood, L.; Balling, R.; Auffray, C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol. J. 2012, 7, 992-1001. [CrossRef] [PubMed]